The Latest Breaking News from Pfizer

The health department is expected to make a decision on the fifth dose within weeks. Here's what we know so far.

Pfizer called for steep declines this year from its Covid vaccine and antiviral pill, but Pfizer stock reversed higher Tuesday.

The Dow Jones reversed lower Tuesday, as the Fed's two-day meeting kicks off today. Caterpillar, Exxon and Pfizer dropped on earnings.

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.

Some people in Hong Kong have been acting suspiciously to get their hands on Covid-19 antiviral drugs, the Post has learned, with one person going to six doctors in a single day asking for the same medicine.

Activist group Project Veritas 'sting' has been spreading on twitter

Emily O'Reilly, who heads the EU Ombudsman, says she has been stonewalled by the European Commission when asking for information in relation to the "Pfizergate" affair. At the core of this controversy is an exchange of text messages between the EU Commission chief and the CEO of Pfizer in the…

Novavax plans to update its Covid vaccine for new variants, and NVAX stock outperformed its vaccine stock rivals.

The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot

New data from one U.S. Centers for Disease Control and Prevention (CDC) database shows a possible stroke risk link for older adults who received an updated Pfizer/BioNTech COVID-19 booster shot, but the signal is weaker than what the agency had flagged earlier in January, health officials said on Thursday.

The Packers quarterback gets asked about trade rumors, calls out woke culture, Big Pharma.